Revolution Medicines, Inc. (Nasdaq:RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that nine oral and poster ...
ImmunityBio, Inc. remains a Buy, with Anktiva’s regulatory and global expansion driving the investment thesis. Learn more ...
The "Checkpoint Inhibitor Refractory Cancer Drugs Market -- Growth, Share, Opportunities & Competitive Analysis, 2025 -- 2032" report has been added to the Credence Research Inc. offering. The global ...
BBO-11818 is a selective, orally bioavailable non-covalent inhibitor that targets KRAS in both the ON and OFF states, has high selectivity over ...
This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...
Fewer congressional contests are expected to be competitive this fall, compared with past election cycles, and experts say the extraordinary mid-decade redistricting efforts initiated by President ...
Tom Brady left the NFL several years ago. But even now, three years later, he seems to make headlines just as often as he did as a player. He does have his hand in quite a few pies after all. And one ...
Berkeley signed a five-year, no-bid contract with Community Conservation Centers to process the city’s recycled materials in 2021. An audit found the deal should have been subject to competitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results